Schedule 13G ownership disclosure

Benitec Biopharma Inc

Common Stock, par value $0.0001 · CUSIP: 08205P209

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Franklin Resources, Inc.

    Shares: 4,144,037.00 · Class: 14.9%

  • Charles B. Johnson

    Shares: 0.00 · Class: 0%

  • Rupert H. Johnson, Jr.

    Shares: 0.00 · Class: 0%

  • Franklin Advisers, Inc.

    Shares: 4,144,037.00 · Class: 14.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000038777-25-000219
Form type
SCHEDULE 13G/A
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Nov 04, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub